You just read:

BiondVax to Provide Update of M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial at 18th MIXiii-BIOMED Conference

News provided by

BiondVax Pharmaceuticals Ltd.

May 13, 2019, 07:00 ET